23andMe founder Anne Wojcicki will regain control of embattled DNA company after all

3 Min Read

In a surprise turn, the founder of 23 Andme and former CEO Anne Wojcicki, prepared to recover control of the DNA company assets, according to a press release from 23Andme Is. In May, a company called Regeneron bought 23 for $ 256 million in a bankruptcy auction, but the non -profit organization of Wojcicki, Tam Research Institute, could break with an “unresolved offer” or $ 305 million, The Wall Street Journal Information.

A bankruptcy judge agreed to make an offer in 23Andme under the condition that they regenerate is the proposition price of Wojcicki in at least $ 10 million, according to WSJ. Regeneon declined, leaving 23 Andme in the Tam control assuming the judge approves the agreement. An audience to consider the New Deal is scheduled for June 17, 2025.

Regeneron had previously planned to keep all the company’s employees and continue to offer consumer DNA test kits. In addition to answering customers’ questions about their ancestry, 23Andme’s genetic data are valuable as a way of identifying possible health risks, and in the case of Regeneron, as a tool to identify medication objectives.

It is not clear what Wojcicki intends to do next, but the 23Andme announcement includes a list of customer data and privacy protections that the Tam research institute agreed, including continuing to eliminate its data and Strextyte Aanstevert aanar Andtext Board and promising to “not sell or transfer the gene data” in the event of another bankruptcy, unless the buyer agrees the buyer. Agreements

Maintaining control of the company’s assets has been Wojcicki’s plan since 23Andme declared bankruptcy in March 2025. It originally resigned as the company’s CEO to make an offer in the company.

“I am delighted that the Tam Research Institute can continue the 23Andme mission to help people access, understand and benefit from the human genome,” says Wojcicki. “We believe it is essential that people have power to have options and transparency with respect to their genetic data and have the opportunity to continue their ancestry and health risk as they want.”

23Andme had a turbulent years before declaring bankruptcy, suffering a data violation in 2023 that hit millions of customers and mass layoffs in 2024 that affected 40 percent of the company’s staff.

Share This Article